Issued Patents All Time
Showing 1–25 of 36 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10919983 | Immunoglobulin variable region cassette exchange | Christopher R. Bebbington, Kenneth Luehrsen | 2021-02-16 |
| 10080792 | Influenza vaccine and therapy | Mark R. Alfenito, Mark Baer, Doris J. Bucher | 2018-09-25 |
| 9290571 | Antibodies to EphA3 | Kenneth Luehrsen, David Martinez, Christina Yi, Christopher R. Bebbington | 2016-03-22 |
| 9127046 | Secretion of antibodies without signal peptides from bacteria | Christopher R. Bebbington | 2015-09-08 |
| 9109032 | Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrow | Varghese Palath, Christopher R. Bebbington, Mark Baer | 2015-08-18 |
| 9045539 | Anti-EMR1 antibodies | Kenneth Luehrsen, Mark Baer, Christopher R. Bebbington, David Martinez, Varghese Palath +3 more | 2015-06-02 |
| 9017674 | Antibodies to granulocyte-macrophage colony-stimulating factor | Christopher R. Bebbington, Kenneth Luehrsen | 2015-04-28 |
| 8877191 | Antibodies to the PcrV antigen of Pseudomonas aeruginosa | Christopher R. Bebbington, Kenneth Luehrsen, Mark Baer | 2014-11-04 |
| 8834870 | Treatment of leukemias and chronic myeloproliferative diseases with antibodies to EphA3 | Christopher R. Bebbington, Varghese Palath | 2014-09-16 |
| 8828393 | Methods for the therapy of inflammatory bowel disease using a type-1 interferon antagonist | Lesley Pickford, Christopher R. Bebbington, David J. King | 2014-09-09 |
| 8664365 | Antibodies to EphA3 | Kenneth Luehrsen, David Martinez, Christina Yi, Christopher R. Bebbington | 2014-03-04 |
| 8642039 | Method of treating a staphylococcus infection in a patient having a low-level pathogenic Pseudomonas aeruginosa infection | — | 2014-02-04 |
| 8637016 | EphA3 antibodies for the treatment of solid tumors | Martin Lackmann, Andrew Scott, Christopher R. Bebbington, Carmelina Murone, Catherine To | 2014-01-28 |
| 8398972 | Methods of treating dementia using a GM-CSF antagonist | Christopher R. Bebbington, Varghese Palath | 2013-03-19 |
| 8211648 | Secretion of antibodies without signal peptides from bacteria | Christopher R. Bebbington | 2012-07-03 |
| 8168183 | Antibodies to granulocyte-macrophage colony-stimulating factor | Christopher R. Bebbington, Kenneth Luehrsen | 2012-05-01 |
| 8075885 | Methods of treating heart failure using an anti-GM-CSF antibody | Christopher R. Bebbington | 2011-12-13 |
| 8044181 | Antibodies to the PcrV antigen of Pseudomonas aeruginosa | Christopher R. Bebbington, Kenneth Luehrsen, Mark Baer | 2011-10-25 |
| 8034787 | Enzyme-cleavable prodrug compounds | Vincent Dubois, Ann Marie Fernandez, Sanjeev Gangwar, Evan Lewis, Thomas J. Lobl +3 more | 2011-10-11 |
| 7981843 | Antibody specificity transfer using minimal essential binding determinants | Peter Flynn, Kenneth Luehrsen, Robert Balint, Jeng-Horng Her, Christopher R. Bebbington | 2011-07-19 |
| 7939076 | Methods for the therapy of Inflammatory Bowel Disease using a type-1 interferon antagonist | Lesley Pickford, Christopher R. Bebbington, David J. King | 2011-05-10 |
| 7816317 | Tripeptide prodrug compounds | Christopher R. Bebbington, Vincent Dubois, Sanjeev Gangwar, Thomas J. Lobl, Matthew H. Nieder +2 more | 2010-10-19 |
| 7696313 | Prodrug compounds with isoleucine | Lesley Pickford, Sanjeev Gangwar, Thomas J. Lobl, Matthew H. Nieder | 2010-04-13 |
| 7425541 | Enzyme-cleavable prodrug compounds | Vincent Dubois, Ann Marie Fernandez, Sanjeev Gangwar, Evan Lewis, Thomas J. Lobl +3 more | 2008-09-16 |
| 7329507 | Prodrug compounds with isoleucine | Lesley Pickford, Sanjeev Gangwar, Thomas J. Lobl, Matthew H. Nieder | 2008-02-12 |